CJC is published 12 times a year.
Sign up for Table of Contents Alerts!
Please note: CJC is published in English and Chinese. Manuscripts are published online prior to printing. The citation will change as volume, issue and page numbers are finalized.
Email this page
Print this page
Mini-review
A Kras-Specific Function in Cancer Initiation
Margaret P. Quinlan and Jeffrey Settleman
volume 27 | issue 7
July 2008Subscribe to this journal for $0/year
The three closely related Ras proteins, Kras, Hras, and Nras constitute the founding members of the Ras superfamily of small GTPases, which serve as molecular switches that relay extracellular signals to a variety of fundamental cellular processes, including proliferation, survival, and differentiation 1, 2. These proteins have been of particular interest to cancer biologists due to the high frequency with which the genes encoding them undergo mutational activation in human cancer 2, 3. Thus, ~30% of all human tumors harbor mutations in Ras genes, as well as mutations in a variety of additional Ras pathway components 4. Ras GTPase signaling is normally self-limiting due to GTP-hydrolysis, which results in the inactivation of the protein, and this property is disrupted upon oncogenic activation due to the fact that the mutations give rise to Ras proteins that remain “locked” in a GTP-bound, active form, resulting in sustained and inappropriate downstream signaling. Despite the natural occurrence of constitutively activating mutations in each of the three Ras genes, mutationally activated Kras is found, by far, at the greatest frequency, occurring in 17-25% of all human tumors.
Authors
Margaret P. Quinlan
Massachusetts General Hospital Cancer Center
Jeffrey Settleman
Massachusetts General Hospital Cancer Center